FDA Webinar on the Food Traceability Final Rule

(2:59:15)

FDA Webinar on the Infant Formula Transition Plan (Part 4)

(1:10:23)

FDA Webinar on the Guidance for Industry on Infant Formula Enforcement Discretion Policy

(44:23)

FDA Webinar on New Infant Formula Transition Plan (Part 2)

(57:22)

FDA Stakeholder Webinar on Action Levels for Lead in Juice: Guidance for Industry

(1:40)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Drugs Day 2

(7:46:19)

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)

(53:23)

FDA Webinar on Allergen Labeling for Retail Food Stores and Food Service Establishments

(32:43)

December 4, 2024 Meeting of the Pharmacy Compounding Advisory Committee (PCAC)

(8:5:29)

FDA Clinical Investigator Training Course (CITC) 2024 – Day Three – Session Two

(1:47:20)

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session Two

(1:42:25)

FDA Clinical Investigator Training Course (CITC) 2024 – Day Two – Session Two

(2:23:52)

2025 Opening Advocacy Webinar

(1:4:3)

Understanding FDA Inspections and Data

(1:56:15)

Webinar: Empowering Independence: ONWARD ARC-EX System granted US market authorization by FDA

(53:53)

FDA Clinical Investigator Training Course (CITC) 2024 – Day One – Session One

(2:14:51)

The FDA Drug Development Process: GLP, GMP and GCP Regulations

(1:31:6)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Devices Day 2/Biologics Day 1

(8:29:5)

Reading of Draft DPDP Rules 2025 | Tsaaro Consulting | Webinar

(46:49)

Framework for FDA’s Real-World Evidence Program – Mar 15, 2019

(49:45)

FDA Tobacco Compliance Webinars: Tobacco Product Listing Updates

(7:8)

FDA Webinar: Action Levels for Lead in Food Intended for Babies and Young Children: Draft Guidance

(1:26)

FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Plenary + Drugs Day 1

(7:42:41)

FDA’s Rulemaking Process and Planned Tobacco Product Standards webinar

(50:53)

FDA Foodborne Outbreak Response Improvement Plan Webinar

(1:3:)

Product Specific Guidances Webinar – Opening Remarks

(12:57)

FSMA Webinar: Final Rule for Produce Safety

(58:47)

FDA Webinar on the Infant Formula Transition Plan (Part 3)

(41:53)

2021 FDA Science Forum: Main Session and Keynote

(56:38)

FDA’s Discussion Paper: 3D Printing Medical Devices at the Point of Care

(55:27)